PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Betamethasone esters
Presentation Product Chemical substance Chapter Items dispensed
Betamethasone dipropionate 0.064% / Clotrimazole 1% cream
1304000D0AACACA
Betamethasone esters Betamethasone esters Skin 29,639
Betamethasone dipropionate 0.05% / Salicylic acid 3% oint
1304000D0AABBBB
Betamethasone esters Betamethasone esters Skin 9,168
Betamethasone diprop 0.05%/Salicylic acid 2% scalp applic
1304000D0AABDBD
Betamethasone esters Betamethasone esters Skin 8,449
Betamethasone dipropionate 0.05% scalp lotion
1304000D0AABCBC
Betamethasone esters Betamethasone esters Skin 3,447
Betamethasone dipropionate 0.05% cream
1304000D0AAAAAA
Betamethasone esters Betamethasone esters Skin 1,752
Betamethasone dipropionate 0.05% ointment
1304000D0AABABA
Betamethasone esters Betamethasone esters Skin 1,633
Betamethasone diprop 0.05% oint 5% in White soft paraffin
1304000D0AACCCC
Betamethasone esters Betamethasone esters Skin 1
Betamethasone diprop 0.05% oint 25% in Emulsifying oint
1304000D0AACBCB
Betamethasone esters Betamethasone esters Skin No data available
Betamethasone diprop 0.05% oint 25% in White soft paraffin
1304000D0AACGCG
Betamethasone esters Betamethasone esters Skin No data available
Betamethasone diprop 0.05% oint 50% in White soft paraffin
1304000D0AACDCD
Betamethasone esters Betamethasone esters Skin No data available
Coal tar 2% in Betamethasone dipropionate 0.05% ointment
1304000D0AACECE
Betamethasone esters Betamethasone esters Skin No data available
Coal tar 5% in Betamethasone dipropionate 0.05% ointment
1304000D0AACFCF
Betamethasone esters Betamethasone esters Skin No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.